Publication:
Controversies in Treating Chronic HBV: The Role of PEG-interferon-alfa

dc.contributor.authorPhunchai Charatcharoenwitthayaen_US
dc.contributor.authorApichat Kaewdechen_US
dc.contributor.authorTeerha Piratvisuthen_US
dc.contributor.otherSiriraj Hospitalen_US
dc.contributor.otherFaculty of Medicine, Prince of Songkia Universityen_US
dc.contributor.otherPrince of Songkla Universityen_US
dc.date.accessioned2022-08-04T09:08:59Z
dc.date.available2022-08-04T09:08:59Z
dc.date.issued2021-11-01en_US
dc.identifier.citationClinics in Liver Disease. Vol.25, No.4 (2021), 741-762en_US
dc.identifier.doi10.1016/j.cld.2021.06.004en_US
dc.identifier.issn15578224en_US
dc.identifier.issn10893261en_US
dc.identifier.other2-s2.0-85111539114en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/77743
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85111539114&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleControversies in Treating Chronic HBV: The Role of PEG-interferon-alfaen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85111539114&origin=inwarden_US

Files

Collections